Characterization of an AML-derived immunomodulatory factor(s) that inhibit T cell activation and the signal transduction pathways involved.

A G S Buggins; M J Arno; A Milojkovic; A Pagliuca; G J Mufti; N S B Thomas; W J R Hirst

Characterization of an AML-derived immunomodulatory factor(s) that inhibit T cell activation and the signal transduction pathways involved.

A G S Buggins, M J Arno, A Milojkovic, A Pagliuca, G J Mufti, N S B Thomas, W J R Hirst

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	501A - 501A
Journal	Blood
Volume	96
Issue number	11
Publication status	Published - 2000

Cite this

@article{528360063d9f4868a0de5c0be403eace,

title = "Characterization of an AML-derived immunomodulatory factor(s) that inhibit T cell activation and the signal transduction pathways involved.",

author = "Buggins, {A G S} and Arno, {M J} and A Milojkovic and A Pagliuca and Mufti, {G J} and Thomas, {N S B} and Hirst, {W J R}",

year = "2000",

language = "English",

volume = "96",

pages = "501A -- 501A",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Characterization of an AML-derived immunomodulatory factor(s) that inhibit T cell activation and the signal transduction pathways involved.

AU - Buggins, A G S

AU - Arno, M J

AU - Milojkovic, A

AU - Pagliuca, A

AU - Mufti, G J

AU - Thomas, N S B

AU - Hirst, W J R

PY - 2000

Y1 - 2000

M3 - Meeting abstract

SN - 1528-0020

VL - 96

SP - 501A - 501A

JO - Blood

JF - Blood

IS - 11

ER -